Viveve Medical (VIVE) Misses Q2 EPS by 11c, Miss on Revenues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts VIVE Hot Sheet
Join SI Premium – FREE
Viveve Medical (NASDAQ: VIVE) reported Q2 EPS of ($0.54), $0.11 worse than the analyst estimate of ($0.43). Revenue for the quarter came in at $3.1 million versus the consensus estimate of $3.24 million.
For earnings history and earnings-related data on Viveve Medical (VIVE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vertex (VERX) Tops Q3 EPS by 4c; Offers Guidance
- eHealth (EHTH) Misses Q3 EPS by 45c
- Enact Holdings (ACT) Reports In-Line Q3 EPS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
